அல் பாதா News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from அல் பாதா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In அல் பாதா Today - Breaking & Trending Today
Q&A: Geoff Walsh, Country Manager DHL Express Saudi | Logistics Middle East logisticsmiddleeast.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from logisticsmiddleeast.com Daily Mail and Mail on Sunday newspapers.
FSD Pharma appoints Adnan Bashir as an independent company director Bashir, a former general manager of Dubai-based business conglomerate Al Batha group, has more than 14 years of experience in strategic management and operations FSD Pharma said Bashir was appointed to fill the vacancy on the board following the resignation of Frank Lavelle FSD Pharma Inc (NASDAQ:HUGE) (CSE:HUGE) (FRA:0K9) announced it has appointed Adnan Bashir as an independent member of the company’s board of directors. Bashir, a former general manager of Dubai-based business conglomerate Al Batha group, has more than 14 years of experience in strategic management and operations. ....
FSD Pharma Inc. Appoints a New Independent Director Search jobs TORONTO (BUSINESS WIRE) $HUGE#HUGE FSD Pharma Inc. (Nasdaq: HUGE) (CSE:HUGE) (FRA:0K9) (the “ Company” or “ FSD”) is pleased to announce the appointment of Mr. Adnan Bashir as an independent member of its Board of Directors (the “ Board”), upon the recommendation of the Company’s Compensation, Nomination and Governance Committee. As previously announced, Mr. Frank Lavelle was elected to the Board at the Company’s annual general and special meeting of shareholders held on May 14 th, 2021 (the “ Meeting”). Shortly after the Meeting, Mr. Lavelle communicated his resignation to the Board, leaving a vacancy, and Mr. Bashir has been appointed to fill that vacancy. The Board considers Mr. Bashir to be “independent” within the meaning of applicable securities legislation. ....
A glance at some of the day s highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive Bioasis Technologies Inc (CVE:BTI) (OTCQB:BIOAF) has announced the publication of research validating the ability of its xB3 platform to cross the intact blood-brain barrier (BBB) and its localization in a variety of brain cell types. The company said research shows that the xB3 platform can cross intact BBB and enter intracellular organelles within neurons, glia and microglia in the brain. It said the data from a study published on June 2 in the Frontiers in Neuroscience provide evidence for the utility of xB3 peptide (previously known as MTfpep) as a platform technology for delivery of recombinant and chemically conjugated drug across the BBB. ....